The European Commission has signed a contract with Sanofi and GlaxoSmithKline (GSK) for 300 million doses of their COVID-19 vaccine for the European Union.

The EU will provide upfront funding to support the scale-up of Sanofi’s and GSK’s manufacturing capabilities in Europe. The contract allows for EU member states to donate doses to lower- and middle-income countries.

The commission has previously signed a contract with AstraZeneca for up to 400 million doses of its vaccine and is in ongoing discussions with other companies for supply deals.